Zynex Gross Margin 2010-2025 | ZYXI
Current and historical gross margin for Zynex (ZYXI) over the last 10 years. The current gross profit margin for Zynex as of March 31, 2025 is %.
| Zynex Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.17B | $0.13B | 77.46% |
| 2024-12-31 | $0.19B | $0.15B | 79.27% |
| 2024-09-30 | $0.19B | $0.15B | 79.38% |
| 2024-06-30 | $0.19B | $0.15B | 79.38% |
| 2024-03-31 | $0.19B | $0.15B | 79.37% |
| 2023-12-31 | $0.18B | $0.15B | 79.35% |
| 2023-09-30 | $0.19B | $0.15B | 79.57% |
| 2023-06-30 | $0.18B | $0.14B | 79.21% |
| 2023-03-31 | $0.17B | $0.13B | 78.82% |
| 2022-12-31 | $0.16B | $0.13B | 78.62% |
| 2022-09-30 | $0.15B | $0.12B | 79.33% |
| 2022-06-30 | $0.14B | $0.11B | 79.72% |
| 2022-03-31 | $0.14B | $0.11B | 79.56% |
| 2021-12-31 | $0.13B | $0.10B | 79.23% |
| 2021-09-30 | $0.12B | $0.09B | 77.59% |
| 2021-06-30 | $0.10B | $0.08B | 77.23% |
| 2021-03-31 | $0.09B | $0.07B | 77.53% |
| 2020-12-31 | $0.08B | $0.06B | 78.75% |
| 2020-09-30 | $0.07B | $0.05B | 79.41% |
| 2020-06-30 | $0.06B | $0.05B | 80.00% |
| 2020-03-31 | $0.05B | $0.04B | 80.39% |
| 2019-12-31 | $0.05B | $0.04B | 80.00% |
| 2019-09-30 | $0.04B | $0.03B | 85.00% |
| 2019-06-30 | $0.04B | $0.03B | 83.33% |
| 2019-03-31 | $0.03B | $0.03B | 82.35% |
| 2018-12-31 | $0.03B | $0.03B | 78.13% |
| 2018-09-30 | $0.03B | $0.02B | 74.19% |
| 2018-06-30 | $0.03B | $0.02B | 73.33% |
| 2018-03-31 | $0.03B | $0.02B | 74.07% |
| 2017-12-31 | $0.02B | $0.02B | 82.61% |
| 2017-09-30 | $0.02B | $0.02B | 94.44% |
| 2017-06-30 | $0.02B | $0.02B | 100.00% |
| 2017-03-31 | $0.01B | $0.01B | 100.00% |
| 2016-12-31 | $0.01B | $0.01B | 76.92% |
| 2016-09-30 | $0.01B | $0.01B | 46.15% |
| 2016-06-30 | $0.01B | $0.01B | 41.67% |
| 2016-03-31 | $0.01B | $0.01B | 41.67% |
| 2015-12-31 | $0.01B | $0.01B | 58.33% |
| 2015-09-30 | $0.01B | $0.01B | 63.64% |
| 2015-06-30 | $0.01B | $0.01B | 66.67% |
| 2015-03-31 | $0.01B | $0.00B | 40.00% |
| 2014-12-31 | $0.01B | $0.00B | 40.00% |
| 2014-09-30 | $0.01B | $0.00B | 36.36% |
| 2014-06-30 | $0.01B | $0.01B | 41.67% |
| 2014-03-31 | $0.02B | $0.01B | 68.75% |
| 2013-12-31 | $0.02B | $0.01B | 66.67% |
| 2013-09-30 | $0.03B | $0.02B | 72.41% |
| 2013-06-30 | $0.03B | $0.03B | 73.53% |
| 2013-03-31 | $0.04B | $0.03B | 74.36% |
| 2012-12-31 | $0.04B | $0.03B | 77.50% |
| 2012-09-30 | $0.04B | $0.03B | 76.92% |
| 2012-06-30 | $0.04B | $0.03B | 76.32% |
| 2012-03-31 | $0.04B | $0.03B | 77.78% |
| 2011-12-31 | $0.03B | $0.03B | 76.47% |
| 2011-09-30 | $0.03B | $0.02B | 77.42% |
| 2011-06-30 | $0.03B | $0.02B | 75.86% |
| 2011-03-31 | $0.03B | $0.02B | 74.07% |
| 2010-12-31 | $0.03B | $0.02B | 76.00% |
| 2010-09-30 | $0.02B | $0.02B | 78.26% |
| 2010-06-30 | $0.02B | $0.02B | 80.95% |
| 2010-03-31 | $0.02B | $0.02B | 84.21% |
| 2009-12-31 | $0.02B | $0.02B | 88.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.066B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.007B | 27.90 |
| Boston Scientific (BSX) | United States | $155.135B | 38.84 |
| Stryker (SYK) | United States | $149.698B | 31.30 |
| EssilorLuxottica (ESLOY) | France | $129.877B | 0.00 |
| Medtronic (MDT) | Ireland | $110.440B | 16.12 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.984B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.101B | 27.36 |
| ResMed (RMD) | United States | $36.449B | 27.38 |
| GE HealthCare Technologies (GEHC) | United States | $33.384B | 15.85 |
| Agilent Technologies (A) | United States | $32.046B | 21.17 |
| Terumo (TRUMY) | Japan | $27.153B | 35.27 |
| Koninklijke Philips (PHG) | Netherlands | $22.822B | 16.41 |
| Insulet (PODD) | United States | $22.662B | 88.96 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.138B | 12.29 |
| Baxter (BAX) | United States | $15.929B | 11.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.591B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.618B | 23.03 |
| Lantheus Holdings (LNTH) | United States | $5.520B | 13.92 |
| Prestige Consumer Healthcare (PBH) | United States | $4.305B | 19.23 |
| Perrigo (PRGO) | Ireland | $3.614B | 9.16 |
| Haemonetics (HAE) | United States | $3.485B | 15.18 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.459B | 25.51 |
| Envista Holdings (NVST) | United States | $3.066B | 25.48 |
| QuidelOrtho (QDEL) | United States | $2.234B | 15.36 |
| GN Store Nord (GNNDY) | Denmark | $2.150B | 17.81 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.07 |
| AtriCure (ATRC) | United States | $1.599B | 0.00 |
| Neogen (NEOG) | United States | $1.424B | 18.22 |
| AdaptHealth (AHCO) | United States | $1.220B | 12.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.209B | 27.19 |
| BioLife Solutions (BLFS) | United States | $1.045B | 0.00 |
| InMode (INMD) | Israel | $1.023B | 9.37 |
| Phibro Animal Health (PAHC) | United States | $0.966B | 12.35 |
| Evolus (EOLS) | United States | $0.645B | 0.00 |
| CeriBell (CBLL) | United States | $0.636B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.586B | 0.00 |
| Owens & Minor (OMI) | United States | $0.548B | 4.54 |
| Valneva SE (VALN) | France | $0.516B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.499B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.443B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.437B | 0.00 |
| Surmodics (SRDX) | United States | $0.401B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.95 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.279B | 49.60 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.47 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| ZimVie (ZIMV) | United States | $0.242B | 11.00 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Brainsway (BWAY) | Israel | $0.188B | 49.90 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.51 |
| Quanterix (QTRX) | United States | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Jin Medical (ZJYL) | China | $0.129B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Exagen (XGN) | United States | $0.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.084B | 10.83 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.57 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |